DMARDs, biologics, corticosteroids, and other established treatments remain the backbone of autoimmune disease management
This piece is written for researchers, clinicians, and scientifically literate readers who want an accurate map: what retatrutide is, why insulin resistance drives PCOS, what the compound has genuinely shown (and in whom), what the closest analog class GLP-1 receptor agonists has shown in actual PCOS trials, how much of any benefit is likely to be weight-mediated versus weight-independent, how it stacks up against the insulin-sensitizing tools PCOS guidelines already endorse, and where the safety and regulatory lines fall
Promoting glycogen breakdown: It encourages the conversion of stored glycogen into glucose, making energy readily available
This encompasses its long-term effectiveness, potential side effects, and differential impacts across various populations
Announcing the collaboration in 2023, GE HealthCare said peripheral focused ultrasound therapy which uses ultrasound to activate the nervous system, stimulating nerve pathways to produce effects such as increased glucose metabolism has potential as a non-invasive, non-pharmacological alternative for chronic disease management
Within 3 d after the switch, an MMTT suggested recovery of basal and postprandial insulin secretion (Table 1b)
